Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

XNK Therapeutics one of three winners of Business Sweden’s Catalyst program 2023

XNK Therapeutics AB today announced that it has been selected as one of three winners of Business Sweden’s Catalyst program 2023. The program identifies Swedish companies having the strongest prerequisites to scale up globally.“We are very grateful to be recognized as one of the most promising Swedish companies by the Catalyst committee. XNK Therapeutics is a pioneer in the development of autologous natural killer (NK) cell-based cancer therapies, with a pipeline consisting of both solid tumor and blood cancer programs. We are looking forward to working with the team from Business Sweden in

Half-Year Operational Update

12 July 2023   IOG plc Half-Year Operational Update IOG plc ("IOG", or "the Company"), (AIM: IOG.L) provides an operational update in advance of the Company's half-year 2023 results. The information contained herein has not been audited and may be subject to further review. An accompanying presentation is available on the IOG website and can be accessed via this link: https://bit.ly/3LuKbPW Rupert Newall, CEO, commented: "Following the successful intervention and production ramp up, the Blythe H2 gas rate has stabilised at 32 mmscf/d, within the 30-40 mmscf/d pre-well

Hexagon strengthens its mining automation and safety solutions with acquisition of HARD-LINE

Hexagon AB, the global leader in digital reality solutions, combining sensor, software and autonomous technologies, today announced the acquisition of HARD-LINE, a fast-growing, global leader in mine automation, remote-control technology and mine production optimisation. HARD-LINE specialises in remote control solutions and related network infrastructure, enabling the tele-remote operation of heavy machinery from a secure control station on the surface or underground, regardless of distance. HARD-LINE’s scalable technologies improve remote-controlled mining operations via electronic and

BULTEN'S Q2 REPORT 2023

Acquisition in Asia, record demand but challenges in the supply chainSecond quarter · Net sales amounted to SEK 1,416 (1,006) million, an increase of 40.8% on the same period the previous year. · Operating earnings (EBIT) totaled SEK 50 (41) million, equating to an operating margin of 3.5% (4.1). · Adjusted operating earnings totaled SEK 58 (51) million, equating to an adjusted operating margin of 4.0% (5.0). Operating earnings have been charged with transaction costs of SEK -8 million attributable to the acquisition of Exim & Mfr Holdings Pte Ltd ("Exim"). The corresponding

Bravida supplies installations amounting to SEK 160 million at Enköping Municipality’s new wastewater treatment plant to reduce effluent discharge into Lake Mälaren

Bravida has been commissioned by Enköping Municipality to carry out electrical, plumbing, sanitation, ventilation and control system installations during construction of a new wastewater treatment plant. The new plant will improve water treatment and help the municipality meet environmental requirements for wastewater.The wastewater treatment plant is an environmental project featuring modern technology that will consist of process buildings and basins that carry out biological and chemical treatment of the water in several stages. The contract also includes offices and service buildings.

Invitation to investor meeting on 17 July at 10:00 CEST

The CEO of Nitro Games Oyj (“Nitro Games” or the “Company”), Jussi Tähtinen, will be presenting the Company at a digital investor meeting on Monday 17 July 2023 starting 10:00 AM CEST. Shareholders, investors and other stakeholders have the opportunity to follow the presentation in real-time and ask questions to the Company during the following Q&A session or, alternatively, watch the event afterwards, on Financial Hearings’ webcast.The investor meeting is held at the following link: https://ir.financialhearings.com/nitro-games-july-2023. Participants can send questions to the presenters

JM Interim Report January–June 2023

HOUSING MARKET CONTINUED TO BE CHALLENGING· Revenue amounted to SEK 7,598m (7,644).  · Operating profit decreased to SEK 676m (898). The operating margin decreased to 8.9 percent (11.8).  · The period was burdened by SEK 67m (0) attributable to implemented savings measures.  · Profit before tax decreased to SEK 626m (868), and profit after tax decreased to SEK 494m (687).  · Return on equity for the past twelve months amounted to 16.4 percent (20.9).  · Earnings per share amounted to SEK 7.50 (10.10).  · Consolidated cash flow including net investment in

First Geoprime® construction project in Denmark: Paving stone saves over 50% CO2

The port of Aalborg in Denmark is the first large-scale concrete construction project to be implemented using the cement-free Geoprime® binder solution developed by Betolar. Denmark's largest concrete manufacturer IBF A/S produced low-carbon paving stones for the 1.5-hectare expansion of the trailer parking area of the country's fourth largest port."The partnership project aimed at halving emissions is ambitious. It has required the close cooperation of the entire value chain. At the same time, it shows that the circular economy solution we have developed that utilizes industrial side

Interim Report for the period April – June 2023

LEQEMBI® approved in the US – the world’s first fully approved disease-modifying treatment for Alzheimer’s disease  Events during the second quarter 2023 · The U.S. Food and Drug Administration’s (FDA) Advisory Committee voted unanimously that the data from BioArctic’s partner Eisai’s Phase 3 Clarity AD clinical trial confirms the clinical benefit of LEQEMBI® (US brand name for lecanemab) · Eisai submitted applications for marketing authorization for lecanemab in South Korea and Great Britain · Health Canada initiated the review of New Drug Submission for lecanemab as

Konecranes’ January-June 2023 half-year financial report will be published on July 26, 2023

KONECRANES PLC PRESS RELEASE July 12, 2023 at 09:00 AM EEST   Konecranes’ January-June 2023 half-year financial report will be published on July 26, 2023   Konecranes will publish its January-June 2023 half-year financial report on Wednesday, July 26, 2023 at approximately 8:30 a.m. EEST. The report will be available on the company’s website at www.konecranes.com after publishing.   A live international webcast and telephone conference for analysts, investors and media will be arranged on the publishing day at 11:30 a.m. EEST. The event will be held in English. The half-

Remedy Entertainment Plc: Publishing time for Half-Year Financial Report 2023

Remedy Entertainment Plc | Press Release July 12, 2023, 09:00 a.m. (EEST) Publishing time for Half-Year Financial Report 2023 Remedy Entertainment Plc will publish its Half-Year Financial Report 2023 on Friday August 11, 2023, at 9:00 a.m. (EEST). Remedy will host a webcast and conference call in English on its financial results for investors, analysts and media on Friday August 11, 2023, at 2:00 p.m. (EEST). Remedy’s financial results will be presented by CEO Tero Virtala and CFO Terhi Kauppi. The half-year report will be available after publication on Remedy’s Investor

Proact demonstrates commitment to information security excellence with ISO 27001 certification in Estonia

Proact, Europe’s leading independent data centre and cloud services provider, has successfully obtained the ISO 27001:2013 certification, a globally recognised standard for information security management systems (ISMS). Such an achievement demonstrates the company's commitment to storing and protecting sensitive information.In Estonia Proact provides infrastructure management, software management as well as private, hybrid and public cloud services. Regardless of service, this certificate reassures the company’s customers and partners that the organisation has enacted strict security

Peab builds elementary school in Höllviken

Peab has been commissioned to build a new elementary school in Höllviken in Vellinge Municipality. The customer is Vellinge Municipality and the contract is worth SEK 281 million.The new Henriksdal School will be a K-9 school with a GFA of 12,300 m2. The school will include a commercial kitchen, a cafeteria and music, home economics and art classrooms as well as a gym for 550 students. The school will be built in architecture typical for Skåne with facades of brick, wood and sheet metal. The building will also meet the requirements and be able to be certified for Miljöbyggnad, level

Sedana Medical informs about adjusted US submission plan following FDA interaction

Sedana Medical AB (publ) today informs that the US Food and Drug Administration (FDA) has requested the company to include long-term outcomes data in the Clinical Study Report (CSR) of the INSPIRE-ICU trials before the New Drug Application (NDA) can be submitted. This is expected to move the filing date by approximately one year to Q1 2025, but is not expected to materially impact the overall cost for the clinical program.INSPIRE-ICU 1&2 are two identical phase III studies to confirm the efficacy and safety of inhaled isoflurane delivered via Sedaconda ACD, compared to IV propofol, for

Fremtind Forsikring - Result 2nd quarter and year to date

SpareBank 1 SR-Bank has an ownership interest of 19,5 % in SpareBank 1 Gruppen AS. Fremtind is 65% owned by SpareBank 1 Gruppen AS. Fremtind's profit before tax as at 30 June 2023 was NOK 346 (706*) million and NOK 280 (525*) million after tax. Isolated for the 2nd quarter, Fremtind's result was -19 (310*) before tax and 7 (233*) million NOK after tax. SpareBank 1 SR-Bank share of Fremtind's profit before tax per 30 June was 44 (89*) million NOK. *Figures in bracket indicate restated figures according to IFRS 17/IFRS 19 for the corresponding period in 2022. Stavanger, 12 July 2023

Growth and strong results in a robust Norwegian economy

DNB’s profit in the second quarter of 2023 was NOK 9 462 million. This is an increase of NOK 1 505 million, or 18.9 per cent, from the corresponding quarter of 2022. “We’re growing in both the personal and corporate customer markets, and we’re pleased that many new customers are choosing us,” says Kjerstin Braathen, Group Chief Executive Officer (CEO) of DNB. Behind the strong results lies a robust Norwegian economy, even though the level of activity in the economy has slowed somewhat during the spring, and general uncertainty has risen. Unemployment remains at a very low level and is

BlueNord Announce Second Quarter 2023 Results

Oslo, 12 July 2023: BlueNord ASA ("BlueNord" or the "Company") today published its second quarter and first half year 2023 results. The second quarter of the year delivered excellent operational performance which supported the overall financial performance of the Company. Highlights:•    Second quarter net hydrocarbon production of 23.6 mboepd, above quarterly guidance of 22.5 - 23.5•    Revenues of USD 191 million for the quarter and USD 411 million for first half of 2023•    EBITDA in Q2 of USD 99 million, delivering EBITDA for H1 of USD 220 million•    Operating Cash Flow in

ShaMaran Operational and Corporate Update

VANCOUVER, BC, July 12, 2023 /CNW/ – ShaMaran Petroleum Corp. (TSX Venture and Nasdaq First North: SNM) (“ShaMaran” or the “Company”) announces an operational and corporate update.  The Company’s operations remain heavily impacted by the continued closure of the Iraq-Turkey pipeline (“ITP”), which has resulted in either a partial or complete shutdown of many fields located in the Kurdistan region of Iraq (“KRI”). ShaMaran understands that negotiations between officials in Iraq and Turkey about re-opening the ITP started in late June and will continue in the weeks ahead. The recent

Heatcube´s high voltage connection to grid at Nordjylland Power Station successfully commissioned

Oslo, Norway 12 July 2023 - Kyoto Group is pleased to announce that the first ever full-scale Heatcube, at the Nordjylland Power Station in Aalborg, Denmark (“Norbis Park”) has now been connected to the grid and the high voltage connection between the transformer building and the world’s largest electrical heater for molten salt, as a key equipment of Heatcube, has been successfully commissioned.The connection and electronical testing of the heater were accompanied by a team of technicians from Vulcanic, the Spirax Sarco company that has delivered the electrical heater to Heatcube at Norbis

Capsol Technologies gains traction in carbon capture from Cement – Awarded feasibility study for large cement plant

Oslo, Norway – 12 July 2023Capsol Technologies has been awarded a feasibility study for the CapsolEoP®(end-of-pipe) carbon capture technology at a cement plant in Northern Europe.The study is for a plant aiming to capture more than 1 million tonnes of CO2 perannum – a significant amount and a significant impact. The award is CapsolTechnologies first paid engineering study on a cement plan. The company isseeing an increasing amount of request and sales engineering work in the cementsector, expecting more engineering studies to be awarded going forward.“The cement industry is

As the growth of streaming slows, service providers need to exploit their opportunities wisely

Ahead of Netflix’s announcement of its second quarter financial results later this month, Simon-Kucher’s latest study shows that Australian streamers are doubling down on price being the most important purchase criterion, followed by breadth of content available. · Only 36 percent of respondents in Australia indicate they stream more compared to last year, a decline of 13 percentage points as compared to the 2022 study · The gap between free online services and paid subscription services is starting to close, with free online services accounting for 33 percent of total streaming time (

Latest data on lecanemab to be presented at Alzheimer’s Association International Conference (AAIC) 2023

Stockholm, July 12, 2023 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab, an anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer’s disease, at the Alzheimer’s Association International Conference (AAIC). The conference will be held in Amsterdam, the Netherlands and virtually from July 16 to 20, 2023.Key Eisai lecanemab AAIC presentations · Amyloid Reduction and Evidence of Downstream Biomarker ModificationPresentation of results of Aβ, tau, neurodegeneration, gliosis, and imaging biomarkers in the

Filo Extends Aurora 260m Northeast with 1,131m at 0.57% CuEq; Expands Bonita 700m East with 879m at 0.47% CuEq

VANCOUVER, BC, JULY 11, 2023 /CNW/ - Filo Corp. (TSX: FIL) (Nasdaq First North Growth Market: FIL) (OTCQX: FLMMF) (“Filo”, or the “Company”) announces assay results from three holes testing extensions to the Aurora and Bonita Zones and the Gemelos target at the Filo del Sol Project in San Juan, Argentina. Highlights and detailed results are shown below along with accompanying figures: · Drillhole FSDH083 extends the Filo-Aurora trend 260m to the northeast with 1,131m at 0.57% CuEq from 419m including: · 112m at 0.70% CuEq from 560m · 210m at 0.80% CuEq from 970m   ·

Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection

LUND (SWEDEN) – LUND (SWEDEN) – Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, today announced plans to restructure its operations. The company will cease commercialization of its IMMray PanCan-d test in the United States to focus its resources on the further development and clinical testing of the Company’s promising next generation pancreatic cancer detection test.   The next generation assay currently in development is intended to work equally well across multiple patient risk groups. The new test is expected to

There are no items matching the current filter
There are no more items matching the current filter
Back to top